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Introduction
Langerhans cell histiocytosis (LCH) is a rare disorder that in-
volves the clonal proliferation of  the Langerhans cells. LCH is 
often diagnosed in childhood, but any age group can be affected, 
from infancy through adulthood [1]. The cause of  this disease is 
unknown, although many possibilities have been explored. The 
clinical presentation is highly variable. The severity and prognosis 
depend on the type and extent of  organ involvement [3]. The dis-
ease classically presents with three syndromes namely Eosinophil-
ic granuloma, Letterer-Siwe disease and Hand-Schuller-Christian 
disease [4]. Letterer-Siwe disease is the most common and serious 
of  these entities, affecting mainly infants up to two years of  age 
[5]. We present a case of  this rare disease, diagnosed after derma-
tological examination, highlighting its typical aspects.
Case Report
A 5-month-old female infant presented with a progressively wors-
ening generalized rash of  1 month duration, fever, poor feeding, 
and abdominal distension. The examination showed jaundice, 
widespread petechias, telangiectasias, small erythematous papules, 
ulcerative - necrotic lesion and erythematous - vesical - crustry - 
flaky - purpuric lesions on the scalp, trunk, extremities of  upper 
limbs (especially palmar region) and diaper area [Figure 1 and 2]. 
There was also a necrotic lesion on the palate and purpuric - hem-
orrhagic lesions on the oral cavity [Figure 3]. An initial laboratory 
workup revealed anemia, thrombocytopenia, and hepatospleno-
megaly. A working diagnosis of  Langerhans cell histiocytosis was 
reached that was later confirmed with a skin biopsy. Two day later, 
the patient evolved to death due to multiple organs failure.
Discussion
Letterer - Siwe disease (LSD) is a kind of  a histiocytosis, rarely 
seen in clinic. However, its prognosis is poor. Children with less 
than two years of  age, with involvement of  the hematopoietic sys-
tem, skin, liver, lungs, and spleen, even with aggressive treatment, 
may have mortality greater than 50% [3, 5]. The differential diag-
nosis is extensive and includes seborrheic dermatitis, eczema, dia-
per dermatitis, Darier’s disease, urticaria pigmentosa, arthropod 
bites, scabies, leukemia, B- and T-cell lymphomas, and some of  
the non-Langerhans cell histiocytoses (especially indeterminate 
cell histiocytosis, benign cephalic histiocytosis, generalized erup-
tive histiocytosis, and xanthoma disseminatum). Ear involvement 
can easily be mistaken for chronic otitis media or otitis externa [6].
The diagnosis of  LCH is based on morphological, immunohisto-
chemical and ultrastructural features. The standard therapy length 
recommended for LCH involving the spleen, liver, or bone mar-
row (high-risk organs) is now 12 months based upon the DAL-
HX-83 and HISTSOC-LCH-III (NCT00276757) studies. In the 
Histiocyte Society LCH-II and LCH-III studies, the standard arm 
consisted of  vinblastine and prednisone as described above under 
multifocal bone, but 6-mercaptopurine was added to the continu-
ation phase of  the protocol [7].
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Abstract
Langerhans cell histiocytosis is defined as a clonal proliferation of  Langerhans phenotypic-like cells. Letterer-Siwe disease is 
the most common and serious of  these entities, affecting mainly infants up to two years of  age. We present a case of  this rare 
disease, diagnosed after dermatological examination, highlighting its typical aspects.
      Keywords: Langerhans Cell Histiocytosis; Infant; Letterer - Siwe Disease.
Elmahi H, Lahlou A,Gallouj S, Mernissi FZ (2017) Langerhans Cell Histiocytosis: Letterer - Siwe Disease Interest of  Dermatological Signs for Diagnosis. Int J Clin Dermatol Res. 5(4), 
114-115. 115
 OPEN ACCESS                                                                                                                                                                               http://scidoc.org/IJCDR.php
Conclusion
To conclude, the LSD is a rare condition, but, due to its severity, 
dermatologists should be able to recognize its typical dermato-
logical signs, which may be decisive to define the treatment and 
prognosis of  affected patients.
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Figure 1. Jaundice and Erythematous - Vesical - Crustry - Purpuric Lesions on the Scalp, Trunk and Diaper Area.
Figure 2. Erythematous - Vesical - Crustry - Purpuric Lesions Palmar Region.
jaundice, widespread petechias, telangiectasias, small erythematous papules, ulcerative-necrotic lesion and erythematous-vesical-crustry-
flaky-purpuric lesions on the scalp, trunk, extremities of  upper limbs (especially palmar region) and diaper area. There was also a 
necrotic lesion on the palate and purpuric-hemorrhagic lesions on the oral cavity.
Figure 3. A Necrotic Lesion on the Palate and Purpuric - Hemorrhagic Lesions on the Oral Cavity.
